Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
15,072,652
-
Shares change
-
+111,855
-
Total reported value, excl. options
-
$182,072,226
-
Value change
-
-$2,049,598
-
Number of buys
-
31
-
Number of sells
-
-23
-
Price
-
$12.08
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2020
63 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q1 2020.
TransMedics Group, Inc. - Common Stock (TMDX) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,072,652 shares
of 33,940,151 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include ABRAMS CAPITAL MANAGEMENT, L.P. (3,499,859 shares), FMR LLC (3,182,332 shares), CREDIT SUISSE AG/ (1,200,221 shares), BlackRock Inc. (1,080,853 shares), Sandhill Capital Partners LLC (770,998 shares), VANGUARD GROUP INC (672,383 shares), RTW INVESTMENTS, LP (503,266 shares), FEDERATED HERMES, INC. (487,529 shares), Zimmer Partners, LP (470,700 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (459,126 shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.